IL17A and chronic obstructive pulmonary disease: While mast cells are likely involved in both phenotypes, the downstream pathways and predominant inflammatory mediators differ, with chymase-1 and IL-33 being more central in COPD-T and IL-17a and NR1D1 in COPD-B.